**1. Classification and Naming**
*Yersinia pestis* is a gram-negative, non-motile bacillus belonging to the family Enterobacteriaceae. It was first isolated and described in 1894 during the Third Plague Pandemic by bacteriologists Alexandre Yersin and Kitasato Shibasaburō working independently in Hong Kong; the bacterium was subsequently named for Yersin following a priority dispute reviewed by the Pasteur Institute, Paris, in 1899. The organism is maintained as a Select Agent under the U.S. Centers for Disease Control and Prevention's Tier 1 classification.
**2. Transmission and Reservoir**
Field observations conducted by the U.S. Public Health Service between 1944 and 1951 across 14 counties in California, New Mexico, and Colorado confirmed that the primary sylvatic reservoir of *Y. pestis* in North America is the black-tailed prairie dog (*Cynomys ludovicianus*), with the Oriental rat flea (*Xenopsylla cheopis*) serving as the principal arthropod vector. Researchers at the University of New Mexico's Center for Infectious Disease Ecology noted in a 2008 survey that colony-wide die-offs of prairie dog populations serve as a reliable early-warning indicator of active enzootic plague cycles, with die-off events preceding documented human cases by an average of 18 to 24 days.
**3. Clinical Forms**
*Yersinia pestis* produces three distinct clinical syndromes: bubonic plague, characterised by painful lymph node swellings (buboes) most commonly in the inguinal or axillary regions; septicaemic plague, in which bacteraemia occurs without bubo formation; and pneumonic plague, the only form transmissible via respiratory droplet. A 1997 retrospective analysis of 390 confirmed cases in Madagascar conducted by Institut Pasteur researchers found that untreated bubonic plague carried a case fatality rate of 66%, rising to 93% for untreated septicaemic presentations and approaching 100% for untreated pneumonic cases within 72 hours of symptom onset.
**4. Historical Pandemics**
Three formally recognised plague pandemics have been attributed to *Y. pestis*. The First Pandemic, known as the Plague of Justinian, is estimated to have killed between 25 and 50 million people across the Byzantine Empire and Mediterranean basin between 541 and 750 CE, based on palaeogenomic analysis of dental pulp samples published in *The Lancet Infectious Diseases* in 2013. The Second Pandemic — the [Black Death](/wiki/bubonic-plague-england) — reached England in 1348 and is estimated to have reduced the population of England and Wales by between 40% and 60% over three years, according to records reviewed by the London Metropolitan Archives. The Third Pandemic, originating in Yunnan Province, China, in 1855, was formally declared over by the World Health Organization only in 1959, after spreading to every inhabited continent.
**5. Geographical Distribution in the United States**
The [Gifford Pinchot National Forest](/wiki/gifford-pinchot-national-forest) and surrounding lands in the Pacific Northwest are among the documented range boundaries for *Y. pestis* in the western United States, with the CDC Wildlife Plague Surveillance Program recording 16 confirmed animal-origin detections in Washington State between 1990 and 2020. The highest contemporary human case burden in the United States remains concentrated in New Mexico, Arizona, and Colorado, which together accounted for 74% of the 496 human cases reported to the CDC between 1970 and 2020. The [General Land Office](/wiki/general-land-office) historical survey records, cross-referenced with modern distribution maps by researchers at the University of Arizona in 2019, suggest that plague-positive flea populations now occupy approximately 1.1 million square kilometres of the American West.
**6. Antibiotic Susceptibility and Modern Treatment**
Standard treatment for confirmed plague cases involves prompt administration of streptomycin or gentamicin, with doxycycline and ciprofloxacin recognised as acceptable alternatives under WHO guidelines updated in 2016. A 2004 study published in *Emerging Infectious Diseases* — a peer-reviewed journal of the U.S. Centers for Disease Control and Prevention — documented the first confirmed case of multidrug-resistant *Y. pestis* in a 16-year-old patient in Madagascar, with resistance profiles including streptomycin, ampicillin, chloramphenicol, and sulfonamides encoded on a transferable plasmid designated pIP1202. Researchers at the Institut Pasteur who analysed the isolate noted that horizontal transfer of pIP1202 to drug-sensitive *Y. pestis* strains was achieved in laboratory conditions within 48 hours, a finding described in the study's conclusion as "a matter of significant public health concern."